JEAN-LOUIS CONSTANZA

WANDERCRAFT

Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.

dont miss

Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations

The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.

EVEN MORE SEMINARS

  • Rosanne Tyas: Speaking at the European Neurological Convention

    Rosanne Tyas
    Royal Hospital for Neuro-disability

    Music Therapy has much to offer: An overview of the effects of music therapy across different domains in neuro-disability.

  • Andrew Bateman PhD MCSP: Speaking at the European Neurological Convention

    Andrew Bateman PhD MCSP
    University of Essex, School of Health and Social Care

    Neuropsychological Rehabilitation Research: how to win funds and change services

  • Prof Michael Barnes: Speaking at the European Neurological Convention

    Prof Michael Barnes

    The role of cannabis in neurology

  • Dr. Stephen Barabas: Speaking at the European Neurological Convention

    Dr. Stephen Barabas
    K-Laser UK Ltd

    Class IV Therapy Laser for Neurorehabilitation and Pain Management

  • Dr Ines Violante: Speaking at the European Neurological Convention

    Dr Ines Violante
    University of Surrey

    Multimodal brain stimulation in brain injury